▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2954 by analyst upside · 2026-06-27
BLCO
Bausch + Lomb Corporation
Healthcare · Market Cap $6B · P/E 0x
ANALYST PRICE TARGET
+9.5%
implied upside to consensus target
Current Price $16.32
Consensus Target $17.88
Bull Target $21.0
Bear Target $16.0
Analysts Covering 12
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
3
Hold
8
Sell
0
52-Week Low $12.06
52-Week High $18.91
YTD Return -1.6%
FUNDAMENTALS
Market Cap $6B
P/E Ratio (TTM) N/A
Forward P/E 15.2x
EPS (TTM) $-0.62
PEG Ratio 0.89
Dividend Yield N/A
Revenue (TTM) $5.2B
Profit Margin -4.2%
52-WEEK RANGE
52-Week Low $12.06
52-Week High $18.91
Current Price $16.32
Bear Target $16.0
Bull Target $21.0
● Now $16.32 ● Target $17.88
TRADING DATA
Avg Volume 455K
YTD Return -1.6%
Analyst Count 12
Consensus Hold
Upside to Target +9.5%
Last Updated 2026-06-27

ANALYST SUMMARY

Bausch + Lomb Corporation (BLCO) is currently trading at $16.32 with a Wall Street consensus price target of $17.88, implying potential upside of 9.5% over the next 12 months. 12 analysts currently cover BLCO, with a consensus rating of Hold - 33% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $21.0, while the most cautious has a target of $16.0.

BLCO operates in the Healthcare sector with a market capitalisation of $6B. The stock is down 1.6% year-to-date and is currently trading near the upper end of its 52-week range of $12.06 – $18.91.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CHE -3.6%
Chemed Corporation
$6B · P/E 24.7x · Hold
PACS +18.6%
PACS Group, Inc.
$7B · P/E 27.0x · Buy
QGEN +11.6%
Qiagen N.V.
$8B · P/E 20.1x · Buy
LGND -8.6%
Ligand Pharmaceuticals Incorporated
$6B · P/E 39.6x · Buy
SHC +16.4%
Sotera Health Company
$5B · P/E 42.4x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for BLCO, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Evercore ISI Group — Reiterated
In-Line → In-Line 2026-04-30 Building track record
Evercore ISI Group — Reiterated
In-Line → In-Line 2026-04-06 Building track record
HC Wainwright & Co. — Reiterated
Buy → Buy 2026-02-23 31% win rate (48 calls)
Citigroup — Reiterated
Buy → Buy 2026-02-19 Building track record
Barclays — Reiterated
Equal-Weight → Equal-Weight 2026-02-19 Building track record
Stifel — Reiterated
Hold → Hold 2026-02-19 Building track record
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2026-02-19 Building track record
Stifel — Reiterated
Hold → Hold 2026-02-17 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
46
out of 100
Coverage depth
20/30
Consensus clarity
24/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →